請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/72553
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 郭柏秀(Po-Hsiu Kuo) | |
dc.contributor.author | Hsin-Ying Lee | en |
dc.contributor.author | 李欣穎 | zh_TW |
dc.date.accessioned | 2021-06-17T07:00:47Z | - |
dc.date.available | 2022-08-26 | |
dc.date.copyright | 2019-08-26 | |
dc.date.issued | 2019 | |
dc.date.submitted | 2019-08-01 | |
dc.identifier.citation | 1. The National Institute of Mental Health Information Resource Center. Any Mood Disorder [Internet]. [cited 2019 Apr 21]. Available from: https://www.nimh.nih.gov/health/statistics/any-mood-disorder.shtml
2. World Health Organization. Depression and Other Common Mental Disorders: Global Health Estimates. 2017. 24 p. 3. Merikangas KR, Jin R, He J-P, Kessler RC, Lee S, Sampson NA, et al. Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative. Arch Gen Psychiatry. 2011 Mar;68(3):241–51. 4. Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G, et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011 Jul 26;9(1):90. 5. Vázquez GH, Holtzman JN, Lolich M, Ketter TA, Baldessarini RJ. Recurrence rates in bipolar disorder: Systematic comparison of long-term prospective, naturalistic studies versus randomized controlled trials. Eur Neuropsychopharmacol. 2015 Oct 1;25(10):1501–12. 6. Verduijn J, Milaneschi Y, Hemert AM van, Schoevers RA, Hickie IB, Penninx BWJH, et al. Clinical Staging of Major Depressive Disorder: An Empirical Exploration. J Clin Psychiatry. 2015 Sep 23;76(9):1200–8. 7. Belmaker RH, Agam G. Major Depressive Disorder. N Engl J Med. 2008 Jan 3;358(1):55–68. 8. Munkholm K, Vinberg M, Berk M, Kessing LV. State-related alterations of gene expression in bipolar disorder: a systematic review. Bipolar Disord. 2012;14(7):684–96. 9. Ciobanu LG, Sachdev PS, Trollor JN, Reppermund S, Thalamuthu A, Mather KA, et al. Differential gene expression in brain and peripheral tissues in depression across the life span: A review of replicated findings. Neurosci Biobehav Rev. 2016 Dec 1;71:281–93. 10. Liew C-C, Ma J, Tang H-C, Zheng R, Dempsey AA. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med. 2006 Mar 1;147(3):126–32. 11. Mostafavi S, Battle A, Zhu X, Potash JB, Weissman MM, Shi J, et al. Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing. Mol Psychiatry. 2014 Dec;19(12):1267–74. 12. Drexhage RC, van der Heul-Nieuwenhuijsen L, Padmos RC, van Beveren N, Cohen D, Versnel MA, et al. Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients. Int J Neuropsychopharmacol. 2010 Nov 1;13(10):1369–81. 13. Otsuki K, Uchida S, Wakabayashi Y, Matsubara T, Hobara T, Funato H, et al. Aberrant REST-mediated transcriptional regulation in major depressive disorder. J Psychiatr Res. 2010 Apr 1;44(6):378–84. 14. Otsuki K, Uchida S, Watanuki T, Wakabayashi Y, Fujimoto M, Matsubara T, et al. Altered expression of neurotrophic factors in patients with major depression. J Psychiatr Res. 2008 Oct 1;42(14):1145–53. 15. Hobara T, Uchida S, Otsuki K, Matsubara T, Funato H, Matsuo K, et al. Altered gene expression of histone deacetylases in mood disorder patients. J Psychiatr Res. 2010 Apr 1;44(5):263–70. 16. Matsubara T, Funato H, Kobayashi A, Nobumoto M, Watanabe Y. Reduced Glucocorticoid Receptor α Expression in Mood Disorder Patients and First-Degree Relatives. Biol Psychiatry. 2006 Apr 15;59(8):689–95. 17. Cheung VG, Conlin LK, Weber TM, Arcaro M, Jen K-Y, Morley M, et al. Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet. 2003 Mar;33(3):422–5. 18. Min JL, Barrett A, Watts T, Pettersson FH, Lockstone HE, Lindgren CM, et al. Variability of gene expression profiles in human blood and lymphoblastoid cell lines. BMC Genomics. 2010 Feb 8;11(1):96. 19. Jansen R, Penninx BWJH, Madar V, Xia K, Milaneschi Y, Hottenga JJ, et al. Gene expression in major depressive disorder. Mol Psychiatry. 2016 Mar;21(3):339–47. 20. Wray NR, Ripke S, Mattheisen M, Trzaskowski M, Byrne EM, Abdellaoui A, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet. 2018 May;50(5):668–81. 21. Howard DM, Adams MJ, Clarke T-K, Hafferty JD, Gibson J, Shirali M, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci. 2019 Mar;22(3):343. 22. Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat Genet. 2019 May;51(5):793. 23. Le TT, Savitz J, Suzuki H, Misaki M, Teague TK, White BC, et al. Identification and replication of RNA-Seq gene network modules associated with depression severity. Transl Psychiatry. 2018 Sep 5;8(1):180. 24. Levinson DF, Mostafavi S, Milaneschi Y, Rivera M, Ripke S, Wray NR, et al. Genetic Studies of Major Depressive Disorder: Why Are There No Genome-wide Association Study Findings and What Can We Do About It? Biol Psychiatry. 2014 Oct 1;76(7):510–2. 25. McKinney BA, White BC, Grill DE, Li PW, Kennedy RB, Poland GA, et al. ReliefSeq: a gene-wise adaptive-K nearest-neighbor feature selection tool for finding gene-gene interactions and main effects in mRNA-Seq gene expression data. PloS One. 2013;8(12):e81527. 26. Torkamani A, Dean B, Schork NJ, Thomas EA. Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia. Genome Res. 2010 Apr;20(4):403–12. 27. Chen C, Cheng L, Grennan K, Pibiri F, Zhang C, Badner JA, et al. Two Gene Co-expression Modules Differentiate Psychotics and Controls. Mol Psychiatry. 2013 Dec;18(12):1308–14. 28. Jong S de, Boks MPM, Fuller TF, Strengman E, Janson E, Kovel CGF de, et al. A Gene Co-Expression Network in Whole Blood of Schizophrenia Patients Is Independent of Antipsychotic-Use and Enriched for Brain-Expressed Genes. PLOS ONE. 2012 Jun 27;7(6):e39498. 29. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature. 2011 May 25;474(7351):380–4. 30. Miller JA, Oldham MC, Geschwind DH. A systems level analysis of transcriptional changes in Alzheimer’s disease and normal aging. J Neurosci Off J Soc Neurosci. 2008 Feb 6;28(6):1410–20. 31. Chang L-C, Jamain S, Lin C-W, Rujescu D, Tseng GC, Sibille E. A Conserved BDNF, Glutamate- and GABA-Enriched Gene Module Related to Human Depression Identified by Coexpression Meta-Analysis and DNA Variant Genome-Wide Association Studies. PLOS ONE. 2014 Mar 7;9(3):e90980. 32. Ciobanu LG, Sachdev PS, Trollor JN, Reppermund S, Thalamuthu A, Mather KA, et al. Co-expression network analysis of peripheral blood transcriptome identifies dysregulated protein processing in endoplasmic reticulum and immune response in recurrent MDD in older adults. J Psychiatr Res. 2018 Dec 1;107:19–27. 33. Wang X, Dalkic E, Wu M, Chan C. Gene module level analysis: identification to networks and dynamics. Curr Opin Biotechnol. 2008 Oct 1;19(5):482–91. 34. Gaiteri C, Ding Y, French B, Tseng GC, Sibille E. Beyond Modules & Hubs: the potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders. Genes Brain Behav. 2014 Jan;13(1):13–24. 35. Roy S, Bhattacharyya DK, Kalita JK. Reconstruction of gene co-expression network from microarray data using local expression patterns. BMC Bioinformatics. 2014 May 28;15(7):S10. 36. Hamilton M. A Rating Scale for Depression. J Neurol Neurosurg Psychiatry. 1960 Feb 1;23(1):56–62. 37. Young RC, Biggs JT, Ziegler VE, Meyer DA. A Rating Scale for Mania: Reliability, Validity and Sensitivity. Br J Psychiatry. 1978 Nov;133(5):429–35. 38. Tsai H-C, Lu M-K, Yang Y-K, Huang M-C, Yeh T-L, Chen W-J, et al. Empirically derived subgroups of bipolar I patients with different comorbidity patterns of anxiety and substance use disorders in Han Chinese population. J Affect Disord. 2012 Jan 1;136(1):81–9. 39. Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014 Aug 1;30(15):2114–20. 40. Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015 Apr;12(4):357–60. 41. Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014 Apr 1;30(7):923–30. 42. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014 Dec 5;15(12):550. 43. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008 Dec 29;9(1):559. 44. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007 Jan 1;8(1):118–27. 45. Gaiteri C, Ding Y, French B, Tseng GC, Sibille E. Beyond modules and hubs: the potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders. Genes Brain Behav. 2014 Jan 1;13(1):13–24. 46. Watanabe K, Taskesen E, Bochoven A van, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017 Nov 28;8(1):1826. 47. Lee S, Wu MC, Lin X. Optimal tests for rare variant effects in sequencing association studies. Biostatistics. 2012 Sep 1;13(4):762–75. 48. Lee S, Emond MJ, Bamshad MJ, Barnes KC, Rieder MJ, Nickerson DA, et al. Optimal Unified Approach for Rare-Variant Association Testing with Application to Small-Sample Case-Control Whole-Exome Sequencing Studies. Am J Hum Genet. 2012 Aug 10;91(2):224–37. 49. Li B, Leal SM. Methods for Detecting Associations with Rare Variants for Common Diseases: Application to Analysis of Sequence Data. Am J Hum Genet. 2008 Sep 12;83(3):311–21. 50. Madsen BE, Browning SR. A Groupwise Association Test for Rare Mutations Using a Weighted Sum Statistic. PLOS Genet. 2009 Feb 13;5(2):e1000384. 51. Morris AP, Zeggini E. An evaluation of statistical approaches to rare variant analysis in genetic association studies. Genet Epidemiol. 2010 Feb;34(2):188–93. 52. Price AL, Kryukov GV, de Bakker PIW, Purcell SM, Staples J, Wei L-J, et al. Pooled Association Tests for Rare Variants in Exon-Resequencing Studies. Am J Hum Genet. 2010 Jun 11;86(6):832–8. 53. Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X. Rare-Variant Association Testing for Sequencing Data with the Sequence Kernel Association Test. Am J Hum Genet. 2011 Jul 15;89(1):82–93. 54. McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The Ensembl Variant Effect Predictor. Genome Biol. 2016 Jun 6;17(1):122. 55. Mahajan GJ, Vallender EJ, Garrett MR, Challagundla L, Overholser JC, Jurjus G, et al. Altered neuro-inflammatory gene expression in hippocampus in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Mar 2;82:177–86. 56. Pantazatos SP, Huang Y-Y, Rosoklija GB, Dwork AJ, Arango V, Mann JJ. Whole-transcriptome brain expression and exon-usage profiling in major depression and suicide: evidence for altered glial, endothelial and ATPase activity. Mol Psychiatry. 2017 May;22(5):760–73. 57. Liu Z, Li X, Sun N, Xu Y, Meng Y, Yang C, et al. Microarray Profiling and Co-Expression Network Analysis of Circulating lncRNAs and mRNAs Associated with Major Depressive Disorder. PLOS ONE. 2014 Mar 27;9(3):e93388. 58. Yi Z, Li Z, Yu S, Yuan C, Hong W, Wang Z, et al. Blood-Based Gene Expression Profiles Models for Classification of Subsyndromal Symptomatic Depression and Major Depressive Disorder. PLOS ONE. 2012 Feb 13;7(2):e31283. 59. Ching T, Huang S, Garmire LX. Power analysis and sample size estimation for RNA-Seq differential expression. RNA. 2014 Nov;20(11):1684–96. 60. Wang KC, Chang HY. Molecular Mechanisms of Long Noncoding RNAs. Mol Cell. 2011 Sep 16;43(6):904–14. 61. Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature. 2012 Feb;482(7385):339–46. 62. Haberman Y, BenShoshan M, Di Segni A, Dexheimer PJ, Braun T, Weiss B, et al. Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease. Inflamm Bowel Dis. 2018 Jan 18;24(2):346–60. 63. Wang S, Hou Y, Chen W, Wang J, Xie W, Zhang X, et al. KIF9‑AS1, LINC01272 and DIO3OS lncRNAs as novel biomarkers for inflammatory bowel disease. Mol Med Rep. 2018 Feb 1;17(2):2195–202. 64. Swan M, Doan N, Ortega RA, Barrett M, Nichols W, Ozelius L, et al. Neuropsychiatric characteristics of GBA-associated Parkinson disease. J Neurol Sci. 2016 Nov 15;370:63–9. 65. Goswami DB, Jernigan CS, Chandran A, Iyo AH, May WL, Austin MC, et al. Gene expression analysis of novel genes in the prefrontal cortex of major depressive disorder subjects. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:126–33. 66. Duclot F, Kabbaj M. The Role of Early Growth Response 1 (EGR1) in Brain Plasticity and Neuropsychiatric Disorders. Front Behav Neurosci [Internet]. 2017 [cited 2019 Jul 26];11. Available from: https://www.frontiersin.org/articles/10.3389/fnbeh.2017.00035/full 67. Covington HE, Lobo MK, Maze I, Vialou V, Hyman JM, Zaman S, et al. Antidepressant Effect of Optogenetic Stimulation of the Medial Prefrontal Cortex. J Neurosci. 2010 Dec 1;30(48):16082–90. 68. Yamada K, Gerber DJ, Iwayama Y, Ohnishi T, Ohba H, Toyota T, et al. Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. Proc Natl Acad Sci. 2007 Feb 20;104(8):2815–20. 69. Kimoto S, Bazmi HH, Lewis DA. Lower Expression of Glutamic Acid Decarboxylase 67 in the Prefrontal Cortex in Schizophrenia: Contribution of Altered Regulation by Zif268. Am J Psychiatry. 2014 Sep 1;171(9):969–78. 70. Trzaskowski M, Eley TC, Davis OSP, Doherty SJ, Hanscombe KB, Meaburn EL, et al. First Genome-Wide Association Study on Anxiety-Related Behaviours in Childhood. PLOS ONE. 2013 Apr 2;8(4):e58676. 71. Grozdanov V, Bliederhaeuser C, Ruf WP, Roth V, Fundel-Clemens K, Zondler L, et al. Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients. Acta Neuropathol (Berl). 2014 Nov 1;128(5):651–63. 72. Ollila HM, Utge S, Kronholm E, Aho V, Van Leeuwen W, Silander K, et al. TRIB1 constitutes a molecular link between regulation of sleep and lipid metabolism in humans. Transl Psychiatry. 2012 Mar;2(3):e97. 73. Hamshere ML, Walters JTR, Smith R, Richards AL, Green E, Grozeva D, et al. Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol Psychiatry. 2013 Jun;18(6):708–12. 74. Fukuda T, Sugita S, Inatome R, Yanagi S. CAMDI, a Novel Disrupted in Schizophrenia 1 (DISC1)-binding Protein, Is Required for Radial Migration. J Biol Chem. 2010 Dec 24;285(52):40554–61. 75. Johnstone M, Maclean A, Heyrman L, Lenaerts A-S, Nordin A, Nilsson L-G, et al. Copy Number Variations in DISC1 and DISC1-Interacting Partners in Major Mental Illness. Mol Neuropsychiatry. 2015;1(3):175–90. 76. Tomppo L, Ekelund J, Lichtermann D, Veijola J, Järvelin M-R, Hennah W. DISC1 Conditioned GWAS for Psychosis Proneness in a Large Finnish Birth Cohort. PLOS ONE. 2012 Feb 17;7(2):e30643. 77. Rathore N, Ramani SR, Pantua H, Payandeh J, Bhangale T, Wuster A, et al. Paired Immunoglobulin-like Type 2 Receptor Alpha G78R variant alters ligand binding and confers protection to Alzheimer’s disease. PLOS Genet. 2018 Nov 2;14(11):e1007427. 78. Yang C-W, Hojer CD, Zhou M, Wu X, Wuster A, Lee WP, et al. Regulation of T Cell Receptor Signaling by DENND1B in TH2 Cells and Allergic Disease. Cell. 2016 Jan 14;164(1):141–55. 79. Prashar A, Schnettger L, Bernard EM, Gutierrez MG. Rab GTPases in Immunity and Inflammation. Front Cell Infect Microbiol [Internet]. 2017 Sep 29 [cited 2019 Jul 4];7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627064/ 80. Yang C-Y, Chen J-B, Tsai T-F, Tsai Y-C, Tsai C-Y, Liang P-H, et al. CLEC4F Is an Inducible C-Type Lectin in F4/80-Positive Cells and Is Involved in Alpha-Galactosylceramide Presentation in Liver. PLOS ONE. 2013 Jun 6;8(6):e65070. 81. Yang W, Zhao X, Tao Y, Wu Y, He F, Tang L. Proteomic analysis reveals a protective role of specific macrophage subsets in liver repair. Sci Rep. 2019 Feb 27;9(1):2953. 82. Gao H, Zhao L, Wang H, Xie E, Wang X, Wu Q, et al. Metal transporter Slc39a10 regulates susceptibility to inflammatory stimuli by controlling macrophage survival. Proc Natl Acad Sci. 2017 Dec 5;114(49):12940–5. 83. Barnes J, Mondelli V, Pariante CM. Genetic Contributions of Inflammation to Depression. Neuropsychopharmacology. 2017 Jan;42(1):81–98. 84. Wohleb ES, Franklin T, Iwata M, Duman RS. Integrating neuroimmune systems in the neurobiology of depression. Nat Rev Neurosci. 2016 Aug;17(8):497–511. 85. Maes M, Scharpé S, Meltzer HY, Bosmans E, Suy E, Calabrese J, et al. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res. 1993 Oct 1;49(1):11–27. 86. Steiner J, Walter M, Gos T, Guillemin GJ, Bernstein H-G, Sarnyai Z, et al. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflammation. 2011 Aug 10;8(1):94. 87. Szelényi J. Cytokines and the central nervous system. Brain Res Bull. 2001 Mar 1;54(4):329–38. 88. Syken J, Shatz CJ. Expression of T cell receptor βlocus in central nervous system neurons. Proc Natl Acad Sci. 2003 Oct 28;100(22):13048–53. 89. Gladkevich A, Kauffman HF, Korf J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2004 May 1;28(3):559–76. 90. Luxton GWG, Gomes ER, Folker ES, Vintinner E, Gundersen GG. Linear Arrays of Nuclear Envelope Proteins Harness Retrograde Actin Flow for Nuclear Movement. Science. 2010 Aug 20;329(5994):956–9. 91. Yu J, Lei K, Zhou M, Craft CM, Xu G, Xu T, et al. KASH protein Syne-2/Nesprin-2 and SUN proteins SUN1/2 mediate nuclear migration during mammalian retinal development. Hum Mol Genet. 2011 Mar 15;20(6):1061–73. 92. Leightner AC, Hommerding CJ, Peng Y, Salisbury JL, Gainullin VG, Czarnecki PG, et al. The Meckel syndrome protein meckelin (TMEM67) is a key regulator of cilia function but is not required for tissue planar polarity. Hum Mol Genet. 2013 May 15;22(10):2024–40. 93. Dawe HR, Smith UM, Cullinane AR, Gerrelli D, Cox P, Badano JL, et al. The Meckel-Gruber Syndrome proteins MKS1 and meckelin interact and are required for primary cilium formation. Hum Mol Genet. 2007 Jan 15;16(2):173–86. 94. Reheman A, Tasneem S, Ni H, Hayward CPM. Mice with deleted multimerin 1 and alpha-synuclein genes have impaired platelet adhesion and impaired thrombus formation that is corrected by multimerin 1. Thromb Res. 2010 May;125(5):e177-183. 95. Tasneem S, Adam F, Minullina I, Pawlikowska M, Hui SK, Zheng S, et al. Platelet adhesion to multimerin 1 in vitro: influences of platelet membrane receptors, von Willebrand factor and shear. J Thromb Haemost JTH. 2009 Apr;7(4):685–92. 96. Wang W, Zhang W, Han Y, Chen J, Wang Y, Zhang Z, et al. NELIN, a new F-actin associated protein, stimulates HeLa cell migration and adhesion. Biochem Biophys Res Commun. 2005 May 20;330(4):1127–31. 97. Olivier JDA, Åkerud H, Skalkidou A, Kaihola H, Sundström-Poromaa I. The effects of antenatal depression and antidepressant treatment on placental gene expression. Front Cell Neurosci [Internet]. 2015 [cited 2019 Jul 15];8. Available from: https://www.frontiersin.org/articles/10.3389/fncel.2014.00465/full 98. Norris FA, Atkins RC, Majerus PW. The cDNA Cloning and Characterization of Inositol Polyphosphate 4-Phosphatase Type II EVIDENCE FOR CONSERVED ALTERNATIVE SPLICING IN THE 4-PHOSPHATASE FAMILY. J Biol Chem. 1997 Sep 19;272(38):23859–64. 99. Kuwasako K, Shimekake Y, Masuda M, Nakahara K, Yoshida T, Kitaura M, et al. Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling. J Biol Chem. 2000 Sep 22;275(38):29602–9. 100. Tochigi M, Iwamoto K, Bundo M, Sasaki T, Kato N, Kato T. Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neurosci Res. 2008 Feb 1;60(2):184–91. 101. Gao L, Gao Y, Xu E, Xie J. Microarray Analysis of the Major Depressive Disorder mRNA Profile Data. Psychiatry Investig. 2015 Jul;12(3):388–96. 102. Aston C, Jiang L, Sokolov BP. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry. 2005 Mar;10(3):309. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/72553 | - |
dc.description.abstract | 情感性疾患是一種嚴重且具遺傳性的精神疾病,其主要包括兩種疾病:重度憂鬱症以及躁鬱症。情感性疾患高頻率的反覆發作以及慢性進程,在個人、家庭,以及社會層面都造成了相當嚴重的負擔,其中鬱症的反覆發作是重度憂鬱症以及躁鬱症重要的共同特徵。然而目前對於病人急性鬱症發作期與緩解期間,基因表現變化差異的研究相當稀少。
本研究納入了12位情感性疾患患者,從患者急性鬱症發作,追蹤至少兩個月至緩解,並同時在急性期及緩解期抽血。我們使用RNA定序,針對同一人前後測進行比較來減少個體間差異所造成的干擾,使用差異表現分析找出與鬱症相關的生物標記,同時建構與鬱症發作相關的基因網路,以找出基因共同表現模組,並進一步使用功能性分析探討差異表現基因以及模組背後的生物功能。在差異表現分析結果中,我們偵測到一些和鬱症相關的基因,其中有部分基因曾在過去研究中被發現和精神疾病相關,而形態發生、細胞發育、細胞遷移及免疫系統功能相關的基因,都在差異表現基因中佔相當高的比例。在基因網路分析中,我們找到兩個與鬱症發作顯著相關的模組,而這些模組中也有高比例的基因與免疫相關功能有關。 本研究的另一個目標,是找出鬱症發作相關狀態生物標記以及重鬱症相關疾病生物標記之間的重疊。重鬱症相關生物標記包括常見及罕見遺傳變異以及過去在重鬱症腦部發現的差異表現基因。分析結果顯示,我們的差異表現基因,顯著包括了許多跟重鬱症相關的生物標記,表示這些差異表現基因,可以提供我們重鬱症以及鬱症發作之間的連結;相反地,模組內並不顯著包含重鬱症相關的基因,表示模組可能指出了單純和鬱症發作相關的基因資訊。未來研究仍需要更大的樣本來驗證本研究找出的生物標記,並進一步確認鬱症發作以及重鬱症之間相關的生物功能。 | zh_TW |
dc.description.abstract | Mood disorders, including major depressive disorder (MDD) and bipolar disorder (BPD), are severe and heritable psychiatric disorders. The high frequency of episode recurrence and disease chronicity cause great disease burden to individuals, families, and societies. For the recurrence of episode, depressive episode is suffered by both major depressive disorder (MDD) and bipolar disorder (BPD) patients. To better understand the underlying biological mechanisms of depressive episode, we aimed to investigate transcriptome changes between acute episode versus remission status for depressive episode among patients with MDD or BPD using RNA sequencing.
We recruited 12 clinically diagnosed patients with BPD or MDD, who were repeatedly measured for their severity of depressive symptoms using Hamilton Depression Rating Scale (HAMD) during episode (HAMD score>=16), and follow-up for at least two-months till remission (HAMD score<=8). Blood samples were drawn at the time of depression severity assessment. We employed differential expression analysis with intra-individual comparison and gene co-expression analysis to identify differential expression genes (DEGs) and modules related to depressive episode. We further explore possible explanations of the biological functions in the DEGs and modules using functional enrichment analysis. In differential expression analysis, several DEGs were identified, such as glucosylceramidase beta (GBA, log2FC = -1.54, P = 9.06*10-5) and glutamate ionotropic receptor NMDA type subunit associated protein 1 (GRINA, log2FC = -0.54, P = 9.84*10-4), both of which have been mentioned in previous depression studies. A variety of functions were overrepresented in our DEGs, such as GOs related to morphogenesis, cellular development, cell movement, as well as immune system. In co-expression network, we detected two modules related to depressive state, and the immune system also stood out in modules associated with depressive state. Another aim of our study is to find out overlapped genes between depressive state markers and trait markers, including genetic variants and brain expression markers associated with MDD. Results revealed that trait markers were enriched in our DEGs, but not in modules related to depressive state. This indicated that the DEGs might give clues to the connection of biological functions between depressive state and trait, while the modules implied state-specific information. Further studies with a bigger sample size are needed to examine the targets detected in our study in order to identify reliable biomarkers for depressive state and confirm the biological connection between depressive state and trait. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T07:00:47Z (GMT). No. of bitstreams: 1 ntu-108-R06849009-1.pdf: 8697315 bytes, checksum: c950b409eb37d35964b98638fc4f1770 (MD5) Previous issue date: 2019 | en |
dc.description.tableofcontents | 論文口試委員審定書 I
誌謝 II 中文摘要 III ABSTRACT IV CONTENTS VI LIST OF FIGURES IX LIST OF TABLES X CHAPTER 1 INTRODUCTION 1 1.1 MOOD DISORDER 1 1.2 DEPRESSIVE EPISODE IN MOOD DISORDER 2 1.3 GENE EXPRESSION IN DEPRESSIVE STATE 3 1.4 INTRA-INDIVIDUAL COMPARISON FOR DETECTING TRANSCRIPTOMIC CHANGES 4 1.5 CO-EXPRESSION NETWORK FOR DETECTING TRANSCRIPTOMIC CHANGE 5 1.6 AIMS 6 CHAPTER 2 MATERIAL AND METHODS 7 2.1 SUBJECTS 7 2.2 ASSESSMENT 8 2.3 RNA EXTRACTION AND SEQUENCING LIBRARY PREPARATION 9 2.4 HIGH-THROUGHPUT TRANSCRIPTOME SEQUENCING 10 2.5 DIFFERENTIAL EXPRESSION ANALYSIS 11 2.6 GENE CO-EXPRESSION NETWORK ANALYSIS 12 2.7 FUNCTIONAL ENRICHMENT AND TISSUE SPECIFICITY ANALYSIS 13 2.8 ENRICHMENT AND ASSOCIATION TEST FOR TRAIT GENETIC VARIANTS 14 2.8.1 Rare-Variant Association Test 14 2.8.2 GWAS Enrichment Analysis of Taiwan MDD 15 2.8.3 GWAS Enrichment Analysis of European Depression 16 2.9 BRAIN-EXPRESSED DEG ENRICHMENT ANALYSIS 18 2.10 DEPRESSIVE-STATE DEG ENRICHMENT ANALYSIS IN MODULES 19 CHAPTER 3 RESULTS 20 3.1 DEMOGRAPHICS AND SEVERITY ASSESSMENT 20 3.2 DIFFERENTIAL EXPRESSION ANALYSIS 21 3.3 FUNCTIONAL ENRICHMENT AND TISSUE SPECIFICITY ANALYSIS IN DEGS 22 3.4 ENRICHMENT AND ASSOCIATION TEST FOR TRAIT MARKERS IN DEGS 23 3.4.1 Rare-Variant Association Test 23 3.4.2 GWAS Enrichment Analysis 23 3.4.3 Brain-expressed DEG Enrichment Analysis in DEGs 23 3.5 GENE CO-EXPRESSION NETWORK ANALYSIS 24 3.6 FUNCTIONAL ENRICHMENT AND TISSUE SPECIFICITY ANALYSIS IN MODULES 25 3.7 ENRICHMENT ANALYSIS FOR TRAIT MARKERS IN MODULES 26 3.7.1 GWAS Enrichment Analysis 26 3.7.2 Brain-expressed DEG Enrichment Analysis in Modules 26 3.8 DEPRESSIVE-STATE DEG ENRICHMENT ANALYSIS IN MODULES 27 CHAPTER 4 DISCUSSION 28 4.1 MAIN FINDINGS 28 4.2 DEPRESSIVE-STATE RELATED GENES 29 4.3 THE OVERLAPPED MARKERS BETWEEN DEPRESSIVE STATE AND TRAIT 32 4.4 MODULES RELATED TO DEPRESSIVE STATE 35 4.5 STRENGTHS AND LIMITATIONS 36 4.6 CONCLUSIONS 37 REFERENCES 38 SUPPLEMENTS 60 | |
dc.language.iso | en | |
dc.title | 使用RNA定序偵測鬱期相關的生物指標 | zh_TW |
dc.title | Depressive State-related Biomarkers Detected by Whole-Blood RNA Sequencing | en |
dc.type | Thesis | |
dc.date.schoolyear | 107-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 盧子彬(Tzu-Pin Lu),蕭朱杏(Chu-Hsing Kate Hsiao),黃名琪(Ming-Chyi Huang) | |
dc.subject.keyword | 鬱症發作,生物標記,差異表現基因,基因共同表現模組,生物功能,重鬱症, | zh_TW |
dc.subject.keyword | depressive state,state marker,differential expression gene (DEG),module,biological function,major depressive disorder (MDD), | en |
dc.relation.page | 87 | |
dc.identifier.doi | 10.6342/NTU201902401 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2019-08-02 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 流行病學與預防醫學研究所 | zh_TW |
顯示於系所單位: | 流行病學與預防醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-108-1.pdf 目前未授權公開取用 | 8.49 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。